These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9355936)

  • 1. Hepatitis A impairs the function of human hepatic CYP2A6 in vivo.
    Pasanen M; Rannala Z; Tooming A; Sotaniemi EA; Pelkonen O; Rautio A
    Toxicology; 1997 Dec; 123(3):177-84. PubMed ID: 9355936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interindividual variability of coumarin 7-hydroxylation in healthy volunteers.
    Rautio A; Kraul H; Kojo A; Salmela E; Pelkonen O
    Pharmacogenetics; 1992 Oct; 2(5):227-33. PubMed ID: 1306122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients.
    Sotaniemi EA; Rautio A; Bäckstrom M; Arvela P; Pelkonen O
    Br J Clin Pharmacol; 1995 Jan; 39(1):71-6. PubMed ID: 7756103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity.
    Kharasch ED; Hankins DC; Taraday JK
    Drug Metab Dispos; 2000 Jan; 28(1):28-33. PubMed ID: 10611136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consumption of watercress fails to alter coumarin metabolism in humans.
    Murphy SE; Johnson LM; Losey LM; Carmella SG; Hecht SS
    Drug Metab Dispos; 2001 Jun; 29(6):786-8. PubMed ID: 11353744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of coumarin metabolism in Turkish population.
    Cok I; Aygün Kocabaş N; Cholerton S; Karakaya AE; Sardaş S
    Hum Exp Toxicol; 2001 Apr; 20(4):179-84. PubMed ID: 11393269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6.
    Hadidi H; Irshaid Y; Vågbø CB; Brunsvik A; Cholerton S; Zahlsen K; Idle JR
    Eur J Clin Pharmacol; 1998 Jul; 54(5):437-41. PubMed ID: 9754990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evaluation of coumarin and nicotine as probe drugs to predict the metabolic capacity of CYP2A6 due to genetic polymorphism in Thais.
    Peamkrasatam S; Sriwatanakul K; Kiyotani K; Fujieda M; Yamazaki H; Kamataki T; Yoovathaworn K
    Drug Metab Pharmacokinet; 2006 Dec; 21(6):475-84. PubMed ID: 17220563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age and CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in man.
    Sotaniemi EA; Lumme P; Arvela P; Rautio A
    Therapie; 1996; 51(4):363-6. PubMed ID: 8953808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose disulfiram does not inhibit CYP2A6 activity.
    Kharasch ED; Hankins DC; Baxter PJ; Thummel KE
    Clin Pharmacol Ther; 1998 Jul; 64(1):39-45. PubMed ID: 9695717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2A6: a human coumarin 7-hydroxylase.
    Pelkonen O; Rautio A; Raunio H; Pasanen M
    Toxicology; 2000 Apr; 144(1-3):139-47. PubMed ID: 10781881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inter-individual Variability of Coumarin 7-hydroxylation (CYP2A6 activity) in an Iranian Population.
    Hassanzadeh Khayyat M; Vahdati Mashhadian N; Eghbal S; Jalali N
    Iran J Basic Med Sci; 2013 Apr; 16(4):610-4. PubMed ID: 24250937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic exposure to low-level cadmium on renal tubular function and CYP2A6-mediated coumarin metabolism in healthy human subjects.
    Satarug S; Nishijo M; Ujjin P; Vanavanitkun Y; Baker JR; Moore MR
    Toxicol Lett; 2004 Mar; 148(3):187-97. PubMed ID: 15041069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cigarette smoking on coumarin metabolism in humans.
    Poland RE; Pechnick RN; Cloak CC; Wan YJ; Nuccio I; Lin KM
    Nicotine Tob Res; 2000 Nov; 2(4):351-4. PubMed ID: 11197315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of coumarin 7-hydroxylation in man.
    Pelkonen O; Rautio A; Raunio H; Mäenpää J; Hakkola J
    J Cancer Res Clin Oncol; 1994; 120 Suppl():S30-1. PubMed ID: 8132700
    [No Abstract]   [Full Text] [Related]  

  • 16. Interindividual variability of coumarin 7-hydroxylation in a Turkish population.
    Iscan M; Rostami H; Iscan M; Güray T; Pelkonen O; Rautio A
    Eur J Clin Pharmacol; 1994; 47(4):315-8. PubMed ID: 7875181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic polymorphism of CYP2A6 activity in a Chinese population.
    Xu P; Huang SL; Zhu RH; Han XM; Zhou HH
    Eur J Clin Pharmacol; 2002 Aug; 58(5):333-7. PubMed ID: 12185557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin.
    Hadidi H; Zahlsen K; Idle JR; Cholerton S
    Food Chem Toxicol; 1997 Sep; 35(9):903-7. PubMed ID: 9409631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
    Draper AJ; Madan A; Parkinson A
    Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An inhibitory monoclonal antibody to human cytochrome P450 2A6 defines its role in the metabolism of coumarin, 7-ethoxycoumarin and 4-nitroanisole in human liver.
    Sai Y; Yang TJ; Krausz KW; Gonzalez FJ; Gelboin HV
    Pharmacogenetics; 1999 Apr; 9(2):229-37. PubMed ID: 10376770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.